Federal contract award
HT942523C0065
DHA SBIR DIRECT TO PHASE II MEDICAL R&D CONTRACT FROM PROPOSAL NO. H2D-0122 FOR "IND-ENABLING STUDIES OF PM-208: A NOVEL PRE-HOSPITAL ANTI-SHOCK THERAPEUTIC"
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | ARMY MED RES ACQ ACTIVITY |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $3.0M |
| Current contract value | $3.0M |
| Potential contract value / ceiling | $3.0M |
| Start date | Sep 15, 2023 |
| Current end date | Jul 14, 2026 |
| Potential end date | Jul 14, 2026 |
| Latest award activity | Jul 29, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 29, 2025 | P00004 | $0 | DEFENSE HEALTH AGENCY SMALL BUSINESS INNOVATION RESEARCH DIRECT TO PHASE II, PROPOSAL H2D-0122, TITLED"IND-ENABLING STUDIES OF PM-208: A NOVEL PRE-HOSPITAL ANTI-SHOCK THERAPEUTIC", MEDICAL RESEARCH AND DEVELOPMENT CONTRACT. |
| Apr 16, 2025 | P00003 | $0 | DHA SBIR D2P II H2D-0122 IND-ENABLED STUDIES OF PM-208 A NOVEL PRE-HOSPITAL ANTI-SHOCK THERAPEUTIC MEDICAL R AND D |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.